{"id":"https://openalex.org/W1892438397","doi":"https://doi.org/10.1200/jco.2001.19.9.2493","title":"Phase I and Pharmacokinetic Study of BMS-184476, a Taxane With Greater Potency and Solubility Than Paclitaxel","display_name":"Phase I and Pharmacokinetic Study of BMS-184476, a Taxane With Greater Potency and Solubility Than Paclitaxel","publication_year":2001,"publication_date":"2001-05-01","ids":{"openalex":"https://openalex.org/W1892438397","doi":"https://doi.org/10.1200/jco.2001.19.9.2493","mag":"1892438397","pmid":"https://pubmed.ncbi.nlm.nih.gov/11331328"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2001.19.9.2493","doi":"https://doi.org/10.1200/jco.2001.19.9.2493","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2001.19.9.2493","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086660695","display_name":"Manuel M. Hidalgo","orcid":"https://orcid.org/0000-0002-3765-3318","observed_orcids":["https://orcid.org/0000-0002-3765-3318"]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]},{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manuel Hidalgo","raw_affiliation_strings":["From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT","institution_ids":["https://openalex.org/I1289568071","https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111672905","display_name":"Cheryl A. Aylesworth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]},{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cheryl Aylesworth","raw_affiliation_strings":["From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT","institution_ids":["https://openalex.org/I1289568071","https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109908656","display_name":"Lisa A. Hammond","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]},{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa A. Hammond","raw_affiliation_strings":["From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT","institution_ids":["https://openalex.org/I1289568071","https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052493398","display_name":"Carolyn D. Britten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]},{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carolyn D. Britten","raw_affiliation_strings":["From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT","institution_ids":["https://openalex.org/I1289568071","https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063294358","display_name":"Geoffrey R. Weiss","orcid":"https://orcid.org/0000-0001-8226-5552","observed_orcids":["https://orcid.org/0000-0001-8226-5552"]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]},{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoffrey Weiss","raw_affiliation_strings":["From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT","institution_ids":["https://openalex.org/I1289568071","https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111501752","display_name":"Joseph Stephenson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]},{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Stephenson","raw_affiliation_strings":["From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT","institution_ids":["https://openalex.org/I1289568071","https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059854677","display_name":"Garry H. Schwartz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]},{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Garry Schwartz","raw_affiliation_strings":["From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT","institution_ids":["https://openalex.org/I1289568071","https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070570779","display_name":"Amita Patnaik","orcid":"https://orcid.org/0000-0002-4144-2193","observed_orcids":["https://orcid.org/0000-0002-4144-2193"]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]},{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amita Patnaik","raw_affiliation_strings":["From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT","institution_ids":["https://openalex.org/I1289568071","https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103604982","display_name":"Lon S. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]},{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lon Smith","raw_affiliation_strings":["From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT","institution_ids":["https://openalex.org/I1289568071","https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063774903","display_name":"Kathleen Molpus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]},{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen Molpus","raw_affiliation_strings":["From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT","institution_ids":["https://openalex.org/I1289568071","https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031228775","display_name":"Sally Felton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]},{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sally Felton","raw_affiliation_strings":["From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT","institution_ids":["https://openalex.org/I1289568071","https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113536414","display_name":"Elora Gupta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]},{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elora Gupta","raw_affiliation_strings":["From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT","institution_ids":["https://openalex.org/I1289568071","https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046598144","display_name":"Karen J. Ferrante","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]},{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen J. Ferrante","raw_affiliation_strings":["From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT","institution_ids":["https://openalex.org/I1289568071","https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031018601","display_name":"Anne Tortora","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]},{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne Tortora","raw_affiliation_strings":["From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT","institution_ids":["https://openalex.org/I1289568071","https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013996692","display_name":"Daryl S. Sonnichsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]},{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daryl S. Sonnichsen","raw_affiliation_strings":["From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT","institution_ids":["https://openalex.org/I1289568071","https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111868610","display_name":"Jamey R. Skillings","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]},{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jamey Skillings","raw_affiliation_strings":["From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT","institution_ids":["https://openalex.org/I1289568071","https://openalex.org/I165951966"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011905014","display_name":"Eric Keith Rowinsky","orcid":"https://orcid.org/0000-0002-0848-4826","observed_orcids":["https://orcid.org/0000-0002-0848-4826"]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]},{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric K. Rowinsky","raw_affiliation_strings":["From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Institute for Drug Development, Cancer Therapy and Research Center and University of Texas Health Science Center at San Antonio; Brooke Army Medical Center, San Antonio, TX; and Bristol-Myers Squibb, Wallingford, CT","institution_ids":["https://openalex.org/I1289568071","https://openalex.org/I165951966"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.913,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.84854005,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"19","issue":"9","first_page":"2493","last_page":"2503"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.671999990940094},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.8769999742507935},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8870000243186951},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8420000076293945},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7250000238418579},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8859999775886536},{"id":"https://openalex.org/keywords/hypersensitivity","display_name":"hypersensitivity","score":0.7360000014305115},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.6759999990463257},{"id":"https://openalex.org/keywords/cholangiocarcinoma","display_name":"cholangiocarcinoma","score":0.9670000076293945},{"id":"https://openalex.org/keywords/gastroesophageal-junction-cancer","display_name":"gastroesophageal junction cancer","score":0.953000009059906},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.4580000042915344},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.5239999890327454}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9069439172744751},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8672084808349609},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.740161657333374},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6874324679374695},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.5904404520988464},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5773354768753052},{"id":"https://openalex.org/C2779802037","wikidata":"https://www.wikidata.org/wiki/Q40878","display_name":"Diarrhea","level":2,"score":0.5122637152671814},{"id":"https://openalex.org/C2778300832","wikidata":"https://www.wikidata.org/wiki/Q1589604","display_name":"Premedication","level":2,"score":0.5095136761665344},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4503737986087799},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.4445953965187073},{"id":"https://openalex.org/C2778594517","wikidata":"https://www.wikidata.org/wiki/Q2260058","display_name":"Chills","level":2,"score":0.44246405363082886},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.441394567489624},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4411202073097229},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39510706067085266},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3360399305820465},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.30308157205581665},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.14150148630142212},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2001.19.9.2493","doi":"https://doi.org/10.1200/jco.2001.19.9.2493","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2001.19.9.2493","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:11331328","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11331328","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G2966921148","display_name":null,"funder_award_id":"MO1\u2010RR\u201001346","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G3548634124","display_name":"GENERAL CLINICAL RESEARCH CENTER","funder_award_id":"M01RR001346","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"}],"funders":[{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W89053777","https://openalex.org/W1723772693","https://openalex.org/W1752100969","https://openalex.org/W1818021918","https://openalex.org/W1836451026","https://openalex.org/W1935541780","https://openalex.org/W2017479143","https://openalex.org/W2046869918","https://openalex.org/W2081318921","https://openalex.org/W2088287882","https://openalex.org/W2089887845","https://openalex.org/W2102903528","https://openalex.org/W2114612380","https://openalex.org/W2126077921","https://openalex.org/W2154985964","https://openalex.org/W2160207820","https://openalex.org/W2166153381","https://openalex.org/W2213012239","https://openalex.org/W2222845202","https://openalex.org/W2232368099","https://openalex.org/W2286167422","https://openalex.org/W2367096150","https://openalex.org/W4233628679","https://openalex.org/W4241306045","https://openalex.org/W4255762755"],"related_works":["https://openalex.org/W2123773760","https://openalex.org/W2142093295","https://openalex.org/W2076048091","https://openalex.org/W2153359746","https://openalex.org/W2149737218","https://openalex.org/W1674191906","https://openalex.org/W2125345656","https://openalex.org/W2018238127","https://openalex.org/W2128449202","https://openalex.org/W1992436250"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"assess":[2],"the":[3,61,115,130,137,177,202,216],"feasibility,":[4],"toxicity,":[5,290],"pharmacokinetics,":[6,291],"and":[7,54,63,117,159,194,231,243,252,293,295],"preliminary":[8],"activity":[9],"of":[10,35,65,75,91,108,124,141,174,201,211,227,259,274,289],"BMS-184476":[11,36,76,142,175,212,260,279],"administered":[12],"as":[13,37,264],"a":[14,38,166,171,191,195,206,265],"1-hour":[15,39,266],"intravenous":[16],"(IV)":[17],"infusion":[18,41,268],"every":[19,42,269],"3":[20,43,161,270],"weeks.":[21,271],"PATIENTS":[22],"AND":[23],"METHODS:":[24],"Patients":[25],"with":[26,32,72,94,157,186,197,285],"advanced":[27,188],"solid":[28],"malignancies":[29],"were":[30,57,70,234],"treated":[31,71,113,128],"escalating":[33],"doses":[34],"IV":[40,267],"weeks":[44],"without":[45],"premedication":[46],"to":[47,59,84],"prevent":[48],"hypersensitivity":[49],"reactions":[50],"(HSR).":[51],"Plasma":[52],"sampling":[53],"urine":[55],"collections":[56],"performed":[58],"characterize":[60],"pharmacokinetics":[62,210],"pharmacodynamics":[64],"BMS-184474.":[66],"RESULTS:":[67],"Thirty-four":[68],"patients":[69,112,127],"78":[73],"courses":[74],"at":[77,114,129,176,229],"five":[78],"dose":[79,120,133,139,180,217,254],"levels":[80],"ranging":[81],"from":[82],"20":[83],"80":[85,118],"mg/m2.":[86],"Dose-limiting":[87],"toxicity":[88],"(DLT),":[89],"consisting":[90],"severe":[92,96,99],"neutropenia":[93,156],"fever,":[95],"diarrhea,":[97],"and/or":[98],"mucositis,":[100],"was":[101],"experienced":[102,190],"during":[103,170],"course":[104,173],"1":[105],"by":[106],"six":[107],"nine":[109],"minimally":[110],"pretreated":[111,150],"70":[116],"mg/m2":[119,132,179,263],"level.":[121,181],"In":[122],"contrast,":[123],"15":[125],"assessable":[126],"60":[131,262],"level,":[134],"which":[135],"is":[136,261],"maximum-tolerated":[138],"(MTD)":[140],"on":[143],"this":[144,275],"administration":[145,294],"schedule,":[146],"only":[147],"one":[148],"heavily":[149],"patient":[151,164,185,196],"developed":[152,165],"DLT":[153],"(grade":[154],"4":[155],"fever":[158],"grade":[160,167],"diarrhea).":[162],"One":[163],"2":[168],"HSR":[169],"second":[172],"40":[178],"A":[182],"previously":[183],"untreated":[184,199],"an":[187,198],"cholangiocarcinoma":[189],"partial":[192],"response,":[193],"carcinoma":[200],"gastroesophageal":[203],"junction":[204],"had":[205],"minor":[207],"response.":[208],"The":[209,250,272],"seemed":[213],"linear":[214],"in":[215,287],"range":[218],"studied.":[219],"Mean":[220],"+/-":[221,236,240,245],"SD":[222],"values":[223],"for":[224,255],"clearance,":[225],"volume":[226],"distribution":[228],"steady-state,":[230],"terminal":[232],"half-life":[233],"220":[235],"89":[237],"mL/min/m2,":[238],"402":[239],"231":[241],"L/m2,":[242],"40.8":[244],"21.8":[246],"hours,":[247],"respectively.":[248],"CONCLUSION:":[249],"MTD":[251],"recommended":[253],"phase":[256],"II":[257],"evaluations":[258],"results":[273],"study":[276],"suggest":[277],"that":[278],"may":[280],"have":[281],"several":[282],"advantages":[283],"compared":[284],"paclitaxel":[286],"terms":[288],"pharmaceutics,":[292],"warrants":[296],"further":[297],"clinical":[298],"development.":[299]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}